Artificial Intelligence (AI) in Medical Diagnostics Market

Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (CT, X-Ray, MRI, Ultrasound), Application (IVD, Radiology, CNS, CVS, Ob/Gyn), User (Hospital, Labs), Unmet Need, Key Stakeholders & Buying Criteria - Global Forecast to 2028

Report Code: HIT 7875 Oct, 2023, by marketsandmarkets.com

The global AI in medical diagnostics market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth in this market is driven by influx of big data, increasing cross-industry partnerships & collaborations, rising government initiatives to drive AI-based technologies, availability of funding for AI-based startups.

However, inadequate AI workforce and ambiguous regulatory guidelines for medical software are factors expected to restrain the market growth.

Global AI in medical diagnostics Market Trend

AI in medical diagnostics Market

To know about the assumptions considered for the study, Request for Free Sample Report

AI in medical diagnostics Market

AI in Medical Diagnostics Market Dynamics

Driver: Increasing demand for AI-based solutions to reduce work pressure on radiologists

Over the years, the demand for AI-based solutions has increased considerably in the diagnostics industry as these solutions have immense potential in medical image diagnosis. Some advantages include faster analysis of diagnostic images, efficient interpretation of the smallest possible data often missed by radiologists, and improved imaged triage and clinical decision support.  Radiologists use these solutions to shift their focus from interpreting images to providing better care. According to a study by the Association of American Medical Colleges, the shortage of radiologists could increase to nearly 42,000 by 2033. The US has as few as 100 radiologists per million population. Considering this, radiologists experience tremendous pressure and workload to interpret unlimited diagnostic data.

Restraint: Inadequate AI workforce and ambiguous regulatory guidelines for medical software

AI is a complex system, and companies need a workforce with certain skill sets for developing, managing, and implementing AI systems. For instance, personnel dealing with AI systems should be informed of technologies such as cognitive computing, ML and machine intelligence, deep learning, and image recognition. Additionally, integrating AI solutions into existing systems needs extensive data processing for replicating human brain behavior. Even a small error can result in system failure or negatively affect the desired result. Moreover, the lack of professional standards and certifications in AI/ML technologies is restraining the growth of AI in healthcare.

Challenge: Hesitancy to adopt AI-based technologies

Extensive growth in digital health has allowed healthcare providers to support patients through novel treatment approaches. AI technologies provide doctors tools that facilitate them diagnose and essentially treat patients better. However, there is an observed hesitancy among doctors for the acceptance of new technologies. For instance, medical practitioners have a false impression that AI will replace doctors in the coming years. Doctors and radiologists trust that skills such as empathy and persuasion are human skills; thus, technologies cannot wholly rule out the presence of a doctor. In addition, there is a worry that patients may be greatly inclined toward these technologies and may forgo required in-person treatments, which might also challenge long-term doctor-patient relationships. Several healthcare professionals have doubts about AI’s capabilities in precisely diagnosing patient conditions. Therefore, proving providers that AI-based solutions are cost-effective, efficient, and reliable solutions that provide doctors ease and better patient care is challenging. However, healthcare providers are gradually accepting the likely benefits of AI-based solutions. Hence, there is a probability that in the coming years, doctors and radiologists will be more inclined toward AI-based technologies in healthcare.

Opportunity: Untapped emerging markets

Emerging markets such as India, China, and Brazil are anticipated to provide substantial growth opportunities for players operating in the AI in medical diagnostics market. This can be due to the expanding patient population in these countries. In India, as per National Institute of Health and Family Welfare, it is estimated that there are 2 to 2.5 million cancer patients at any given point; every year, about 0.7 million new cases are reported in the country. Moreover, the healthcare sectors in emerging economies, such as India and China, are rapidly expanding with the introduction of new medical technologies with a particular focus on progressed imaging equipment. All these factors, coupled with the growing population in these countries, are anticipated to increase the medical imaging data volumes in their respective healthcare systems. This gives an untapped development opportunity for AI-based solutions in emerging countries.

AI in medical diagnostics Market Ecosystem

Based on component, software segment accounted for the largest share of the global AI in medical diagnostics industry

Based on component, the AI in medical diagnostics market is bifurcated into software, services, and hardware. The software segment accounted for the largest share of the global AI in medical diagnostics Market in 2022. The large share of this segment is attributed to as the software solutions help healthcare providers  a competitive edge over others, despite the challenges of being short-staffed and challenging increasing imaging scan volumes.

Based on end user ,the hospitals segment accounted for the largest share of the AI in medical diagnostics industry

Based on end users, the AI in medical diagnostics market is bifurcated into hospitals, diagnostic imaging centers, diagnostic laboratories, and other end users. The hospitals segment accounted for the largest share of the global AI in medical diagnostics Market in 2022. Factors such as growing  inclination of hospitals toward the automation and digitization of radiology patient workflow, and growing adoption of minimally invasive procedures in hospitals and healthcare facilities to advance the quality of patient care and focus on patient centric care.

Based on region , North America accounted for the largest share of the global AI in medical diagnostics industry in 2022

In 2022, North America accounted for the largest market share of AI in medical diagnostics market. Factors such as the shortfall of radiologists, the increasing prevalence of chronic diseases, improved research on the ethical implementation of AI in diagnostic tools, and increased funding for research are the key factors driving the growth of this regional market.

AI in medical diagnostics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the prominent players in this market are Microsoft (US), NVIDIA Corporation (US), Merative (US), Intel Corporation (US), Google (US), Siemens Healthineers (Germany), GE HealthCare (US), Digital Diagnostics Inc. (US), Advanced Micro Devices, Inc.  (US), InformAI (US), HeartFlow, Inc. (US), Enlitic, Inc.  (US), icometrix (Belgium), Aidence (Netherlands), Butterfly Network, Inc. (US), Nano-X Imaging LTD. (Israel), Viz.ai, Inc (US), Quibim (Spain), Qure.ai (India), Therapixel (France), Aidoc (US), Koninklijke Philips N.V. (Netherlands), Lunit, Inc. (South Korea), EchoNous, Inc. (US), and Brainomix (UK).

Scope of the AI in Medical Diagnostics Industry:

Report Metric

Details

Market Revenue in 2023

$1.3 billion

Estimated Value by 2028

$3.7 billion

Revenue Rate

Poised to grow at a CAGR of 23.2%

Market Driver

Increasing demand for AI-based solutions to reduce work pressure on radiologists

Market Opportunity

Untapped emerging markets

The study categorizes the AI in medical diagnostics market to forecast revenue and analyze trends in each of the following submarkets:

By Component

  • Software
  • Services
  • Hardware
    • Processors
      • MPU
      • GPU
      • FPGA
      • ASIC
    • Memory
    • Networks
      • Adapters
      • Switches
      • Interconnects

By Application

  • In Vivo diagnostics
    • By Specialty
      • Radiology
      • Cardiology
      • Neurology
      • Obstetrics/gynecology
      • Ophthalmology
      • Other specialties
    • By Modality
      • Computed tomography
      • X- Ray
      • Magnetic resonance imaging
      • Ultrasound
      • Other modalities
    • In Vitro diagnostics

By End User

  • Hospitals
  • Diagnostics Imaging Centers
  • Diagnostics Laboratories
  • Other End User

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Recent Developments of AI in Medical Diagnostics Industry

  • In September 2023, Mayo Clinic (US) and GE HealthCare (US) collaborated on research and product development programs to better equip clinicians and help diagnose and treat medical conditions.
  • In January 2023, Intel Corporation (US) launched 4th Gen Intel Xeon Scalable processors (code-named Sapphire Rapids), the Intel Xeon CPU Max Series (code-named Sapphire Rapids HBM) and the Intel Data Center GPU Max Series (code-named Ponte Vecchio), delivering a leap in data center performance, efficiency, security and new capabilities for AI, the cloud, the network and edge, and the world’s most powerful supercomputers.
  • In October 2022, Google Cloud (US) launched Medical Imaging Suite, a new industry solution that makes imaging healthcare data more accessible, interoperable, and useful. Google Cloud enables the development of AI for imaging to support faster, more precise diagnosis of images, increased productivity for healthcare workers, and improved care access and patient outcomes.
  • In January 2022, Siemens Healthineers (Germany) and Ohio State Wexner Medical Center (US) partnered to provide cutting-edge imaging and treatment technology to Ohio State patient care, research institutions, and the surrounding regions. The alliance offers cutting-edge radiation oncology and advanced imaging modalities on the Outpatient Care West Campus.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 45)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
    1.6 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 49)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
          FIGURE 5 MARKET SIZE ESTIMATION
          TABLE 1 FACTOR ANALYSIS
          FIGURE 6 AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
          FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 8 TOP-DOWN APPROACH
    2.3 MARKET DATA ESTIMATION AND TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS 
    2.5 LIMITATIONS 
           2.5.1 SCOPE-RELATED LIMITATIONS
           2.5.2 METHODOLOGY-RELATED LIMITATIONS
    2.6 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET
    2.7 AI IN MEDICAL DIAGNOSTICS MARKET: RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 62)
    FIGURE 10 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2023 VS. 2028 (USD MILLION)
    FIGURE 11 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION)
    FIGURE 12 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2023 VS. 2028 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET
 
4 PREMIUM INSIGHTS (Page No. - 65)
    4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW 
          FIGURE 14 RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF  BIG DATA TO DRIVE MARKET
    4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET,  BY APPLICATION AND COUNTRY (2022) 
          FIGURE 15 IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA  IN 2022
    4.3 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 16 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE
    4.4 AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL MIX 
          FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.5 AI IN MEDICAL DIAGNOSTICS MARKET:  DEVELOPED MARKETS VS. EMERGING ECONOMIES 
          FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 68)
    5.1 INTRODUCTION 
          FIGURE 19 AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.1.1 DRIVERS
                    5.1.1.1 Influx of big data
                    5.1.1.2 Growing cross-industry partnerships & collaborations
                    5.1.1.3 Increasing demand for AI-based solutions to reduce work pressure on radiologists
                    5.1.1.4 Rising government initiatives to support AI-based technologies
                    5.1.1.5 Availability of funding for AI-based startups
           5.1.2 RESTRAINTS
                    5.1.2.1 Inadequate AI workforce and ambiguous regulatory guidelines for medical software
           5.1.3 OPPORTUNITIES
                    5.1.3.1 Untapped emerging markets
                    5.1.3.2 Increasing focus on developing human-aware AI systems
           5.1.4 CHALLENGES
                    5.1.4.1 Reluctance to adopt AI-based technologies
                    5.1.4.2 Budgetary constraints
                    5.1.4.3 Unstructured healthcare data
                    5.1.4.4 Data privacy concerns
                    5.1.4.5 Limited interoperability
    5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 
          FIGURE 20 REVENUE SHIFT & NEW REVENUE POCKETS FOR AI IN MEDICAL DIAGNOSTICS
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 21 AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN
           5.3.1 UPSTREAM
           5.3.2 MID-STREAM
           5.3.3 DOWNSTREAM
    5.4 ECOSYSTEM MAPPING 
          FIGURE 22 AI IN MEDICAL DIAGNOSTICS MARKET: ECOSYSTEM
           5.4.1 ROLE IN ECOSYSTEM
    5.5 CASE STUDIES 
           5.5.1 MAYO CLINIC INTEGRATES AI-ENABLED DIGITAL DIAGNOSTICS AND BOOSTS MEDICAL RESEARCH WITH GOOGLE CLOUD PLATFORM
           5.5.2 RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES
           5.5.3 NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING
           5.5.4 ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND
           5.5.5 WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS
    5.6 TECHNOLOGY ANALYSIS 
           5.6.1 MACHINE LEARNING
           5.6.2 NATURAL LANGUAGE PROCESSING
           5.6.3 COMPUTER VISION
                    TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 AI IN MEDICAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF SUPPLIERS
           5.7.4 BARGAINING POWER OF BUYERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 INDUSTRY TRENDS 
           5.8.1 ARTIFICIAL INTELLIGENCE IN HEALTHCARE
                    5.8.1.1 Key to AI in Healthcare: Data
                    5.8.1.2 AR and MR in Healthcare Settings
                    5.8.1.3 Healthcare Privacy and Security in 2022
                    5.8.1.4 Growing demand for AI among companies offering at-home IVD testing services
    5.9 TRADE ANALYSIS 
          FIGURE 23 EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
          FIGURE 24 IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
    5.10 TARIFF AND REGULATORY ANALYSIS 
           5.10.1 TARIFF FOR AI IN MEDICAL DIAGNOSTICS HARDWARE
                     TABLE 5 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY US, 2022
                     TABLE 6 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY CHINA, 2022
                     TABLE 7 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY GERMANY, 2020
           5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS
           5.10.3 NORTH AMERICA
                     FIGURE 25 ALGORITHMS CLEARED BY US FDA, 2008 TO 2023
                    5.10.3.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA)
                    5.10.3.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH)
                    5.10.3.3 Consumer Privacy Protection Act of 2017
                    5.10.3.4 National Cybersecurity Protection Advancement Act of 2015
                    5.10.3.5 Future of Life Institute’s Asilomar AI Principles
           5.10.4 EUROPE
                    5.10.4.1 European Medical Devices Regulation (EU) 2017/745 and In-vitro Diagnostic Medical Devices Regulation (EU) 2017/746, in combination with General Data Protection Regulation 2016/679
                    5.10.4.2 AI Act (Artificial Intelligence Act)
           5.10.5 ASIA PACIFIC
                    5.10.5.1 Cybersecurity Law of the People’s Republic of China
           5.10.6 REST OF THE WORLD
                    5.10.6.1 Protection of Personal Information Act
    5.11 PRICING ANALYSIS 
           FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY HARDWARE (PROCESSOR)
           TABLE 12 AVERAGE SELLING PRICE OF PROCESSORS, BY TYPE
           5.11.1 AVERAGE SELLING PRICE TREND
    5.12 PATENT ANALYSIS 
           5.12.1 PATENT PUBLICATION TRENDS FOR ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS
                     FIGURE 27 PATENT PUBLICATION TRENDS (2019-2023)
           5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR AI IN MEDICAL DIAGNOSTICS (2019-2023)
                     TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL DIAGNOSTICS MARKET
    5.13 KEY CONFERENCES AND EVENTS (2023–2024) 
          TABLE 14 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS
                     FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
                     TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
           5.14.2 BUYING CRITERIA
                     FIGURE 30 KEY BUYING CRITERIA FOR END USERS
                     TABLE 17 KEY BUYING CRITERIA FOR END USERS
    5.15 UNMET NEEDS: AI IN MEDICAL DIAGNOSTICS MARKET 
           TABLE 18 AI IN MEDICAL DIAGNOSTICS MARKET: UNMET NEEDS
    5.16 END-USER EXPECTATIONS 
           TABLE 19 AI IN MEDICAL DIAGNOSTICS MARKET: END-USER EXPECTATIONS
    5.17 REIMBURSEMENT SCENARIO 
           TABLE 20 SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE
           TABLE 21 DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT
           5.17.1 REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY
 
6 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY COMPONENT (Page No. - 106)
    6.1 INTRODUCTION 
          TABLE 22 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
          TABLE 23 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
    6.2 SOFTWARE 
           6.2.1 USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS
                    TABLE 24 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 25 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
    6.3 SERVICES 
           6.3.1 RISING NEED TO DEPLOY AND INTEGRATE AI SYSTEMS TO SUPPORT MARKET GROWTH
                    TABLE 26 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 27 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
    6.4 HARDWARE 
           6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
                    TABLE 28 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 29 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 30 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 31 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
           6.4.2 PROCESSORS
                    TABLE 32 PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 33 PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 34 PROCESSORS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                    TABLE 35 PROCESSORS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
                    6.4.2.1 MPU
                               6.4.2.1.1 MPUs to hold largest share of processors market
                                              TABLE 36 MPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 37 MPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
                    6.4.2.2 GPU
                               6.4.2.2.1 GPUs play crucial role in enhancing accuracy and efficacy of imaging
                                              TABLE 38 GPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 39 GPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
                    6.4.2.3 FPGA
                               6.4.2.3.1 Wide usage potential to drive demand
                                              TABLE 40 FPGA MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 41 FPGA MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
                    6.4.2.4 ASIC
                               6.4.2.4.1 Rapid operations to support end-user demand
                                              TABLE 42 ASIC MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 43 ASIC MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
           6.4.3 MEMORY
                    6.4.3.1 Development of high-bandwidth memory for AI applications to drive market
                                TABLE 44 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                                TABLE 45 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
           6.4.4 NETWORKS
                    TABLE 46 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 47 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 48 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 49 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
                    6.4.4.1 Adapters
                               6.4.4.1.1 Adapters to hold largest share of networks market
                                              TABLE 50 ADAPTERS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 51 ADAPTERS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
                    6.4.4.2 Switches
                                TABLE 52 SWITCHES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                                TABLE 53 SWITCHES MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
                    6.4.4.3 Interconnects
                               6.4.4.3.1 Need for efficient data transmission to drive market
                                              TABLE 54 INTERCONNECTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 55 INTERCONNECTS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
 
7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY APPLICATION (Page No. - 129)
    7.1 INTRODUCTION 
          TABLE 56 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
          TABLE 57 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
    7.2 IN VIVO DIAGNOSTICS 
           7.2.1 IN VIVO DIAGNOSTICS MARKET, BY SPECIALTY
                    TABLE 58 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY,  2017–2021 (USD MILLION)
                    TABLE 59 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY,  2022–2028 (USD MILLION)
                    TABLE 60 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES,  BY COUNTRY, 2017–2021 (USD MILLION)
                    TABLE 61 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES,  BY COUNTRY, 2022–2028 (USD MILLION)
                    7.2.1.1 Radiology
                               7.2.1.1.1 AI-based diagnostic tools to reduce work pressure on radiologists
                                              TABLE 62 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 63 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
                    7.2.1.2 Cardiology
                               7.2.1.2.1 Rising complexities associated with CVD to drive market
                                              TABLE 64 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,  2017–2021 (USD MILLION)
                                              TABLE 65 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,  2022–2028 (USD MILLION)
                    7.2.1.3 Neurology
                               7.2.1.3.1 Increasing prevalence of critical brain disorders to drive market
                                              TABLE 66 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY,  2017–2021 (USD MILLION)
                                              TABLE 67 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY,  2022–2028 (USD MILLION)
                    7.2.1.4 Obstetrics/Gynecology
                               7.2.1.4.1 Rising use of minimally invasive techniques in gynecology procedures to drive market
                                              TABLE 68 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 69 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
                    7.2.1.5 Ophthalmology
                               7.2.1.5.1 Rising need for early detection & prevention of eye diseases to drive market
                                              TABLE 70 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY,  2017–2021 (USD MILLION)
                                              TABLE 71 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY,  2022–2028 (USD MILLION)
                    7.2.1.6 Other specialties
                                TABLE 72 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY,  2017–2021 (USD MILLION)
                                TABLE 73 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY,  2022–2028 (USD MILLION)
           7.2.2 IN VIVO DIAGNOSTICS MARKET, BY MODALITY
                    TABLE 74 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY,  2017–2021 (USD MILLION)
                    TABLE 75 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY,  2022–2028 (USD MILLION)
                    TABLE 76 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES,  BY COUNTRY, 2017–2021 (USD MILLION)
                    TABLE 77 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES,  BY COUNTRY, 2022–2028 (USD MILLION)
                    7.2.2.1 CT
                               7.2.2.1.1 Rising availability of cardiac CT devices with AI solutions to drive market
                                              TABLE 78 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2017–2021 (USD MILLION)
                                              TABLE 79 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2022–2028 (USD MILLION)
                    7.2.2.2 X-ray
                               7.2.2.2.1 Innovative AI solutions for x-ray imaging by key players to drive market
                                              TABLE 80 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY,  2017–2021 (USD MILLION)
                                              TABLE 81 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY,  2022–2028 (USD MILLION)
                    7.2.2.3 MRI
                               7.2.2.3.1 Rising technological advancements to drive adoption of  AI in MRI
                                              TABLE 82 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY,  2017–2021 (USD MILLION)
                                              TABLE 83 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY,  2022–2028 (USD MILLION)
                    7.2.2.4 Ultrasound
                               7.2.2.4.1 Increasing prevalence of ovarian cancer to boost demand
                                              TABLE 84 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY,  2017–2021 (USD MILLION)
                                              TABLE 85 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY,  2022–2028 (USD MILLION)
                    7.2.2.5 Other modalities
                                TABLE 86 FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING
                                TABLE 87 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY,  2017–2021 (USD MILLION)
                                TABLE 88 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY,  2022–2028 (USD MILLION)
    7.3 IN VITRO DIAGNOSTICS 
           7.3.1 INCREASING ADOPTION OF POC TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH
                    TABLE 89 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 90 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,  2022–2028 (USD MILLION)
 
8 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY END USER (Page No. - 154)
    8.1 INTRODUCTION 
          TABLE 91 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
          TABLE 92 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
    8.2 HOSPITALS 
           8.2.1 INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET
                    TABLE 93 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 94 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY,  2022–2028 (USD MILLION)
    8.3 DIAGNOSTIC IMAGING CENTERS 
           8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
                    TABLE 95 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY COUNTRY, 2017–2021 (USD MILLION)
                    TABLE 96 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY COUNTRY, 2022–2028 (USD MILLION)
    8.4 DIAGNOSTIC LABORATORIES 
           8.4.1 RISING SPECIMEN TEST VOLUMES TO DRIVE MARKET
                    TABLE 97 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 98 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY,  2022–2028 (USD MILLION)
    8.5 OTHER END USERS 
          TABLE 99 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY,  2017–2021 (USD MILLION)
          TABLE 100 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2028 (USD MILLION)
 
9 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY REGION (Page No. - 162)
    9.1 INTRODUCTION 
          TABLE 101 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2017–2021 (USD MILLION)
          TABLE 102 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2022–2028 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 31 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
                    TABLE 103 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 104 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
                    TABLE 105 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                    TABLE 106 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                    TABLE 107 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                    TABLE 108 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                    TABLE 109 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                    TABLE 110 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                    TABLE 111 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                    TABLE 112 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                    TABLE 113 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                    TABLE 114 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                    TABLE 115 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 116 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 117 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 118 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 119 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                    TABLE 120 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.2.2 US
                    9.2.2.1 Increasing volume of imaging procedures to drive market
                                TABLE 121 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
                                TABLE 122 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
                                TABLE 123 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 124 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 125 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 126 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 127 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
                                TABLE 128 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
                                TABLE 129 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 130 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 131 US: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 132 US: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 133 US: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 134 US: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 135 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
                                TABLE 136 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Research grants and improved academics in radiology to drive market
                                TABLE 137 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 138 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 139 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 140 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 141 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 142 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 143 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 144 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 145 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 146 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 147 CANADA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 148 CANADA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 149 CANADA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 150 CANADA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 151 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                                TABLE 152 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 153 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 154 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
                    TABLE 155 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                    TABLE 156 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                    TABLE 157 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                    TABLE 158 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                    TABLE 159 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                    TABLE 160 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                    TABLE 161 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                    TABLE 162 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                    TABLE 163 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                    TABLE 164 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                    TABLE 165 EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 166 EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 167 EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 168 EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 169 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                    TABLE 170 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Rising government support to drive adoption of AI in medical diagnostics
                                TABLE 171 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 172 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 173 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 174 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 175 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 176 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 177 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 178 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 179 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 180 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 181 GERMANY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 182 GERMANY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 183 GERMANY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 184 GERMANY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 185 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                                TABLE 186 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Availability of funding for companies to enhance AI research in medical imaging
                                TABLE 187 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 188 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 189 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 190 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 191 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 192 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 193 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 194 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 195 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 196 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 197 FRANCE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 198 FRANCE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 199 FRANCE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 200 FRANCE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 201 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                                TABLE 202 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.3.4 UK
                    9.3.4.1 Increasing radiography procedures to drive market
                                TABLE 203 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
                                TABLE 204 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
                                TABLE 205 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 206 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 207 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 208 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 209 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
                                TABLE 210 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
                                TABLE 211 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 212 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 213 UK: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 214 UK: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 215 UK: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 216 UK: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 217 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
                                TABLE 218 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Increasing volume of EHRs and EMRs due to rising geriatric population to drive demand for AI solutions
                                TABLE 219 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 220 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 221 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 222 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 223 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 224 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 225 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 226 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 227 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 228 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 229 ITALY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 230 ITALY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 231 ITALY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 232 ITALY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 233 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
                                TABLE 234 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Growing awareness of AI in Spain to favor market growth
                                TABLE 235 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 236 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 237 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 238 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 239 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 240 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 241 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 242 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 243 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 244 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 245 SPAIN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 246 SPAIN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 247 SPAIN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 248 SPAIN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 249 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
                                TABLE 250 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 251 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                    TABLE 252 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                    TABLE 253 REST OF EUROPE: AI IN MEDICA DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                    TABLE 254 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                    TABLE 255 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                    TABLE 256 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                    TABLE 257 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                    TABLE 258 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                    TABLE 259 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                    TABLE 260 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                    TABLE 261 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 262 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 263 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 264 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 265 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                    TABLE 266 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 32 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
                    TABLE 267 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
                    TABLE 268 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
                    TABLE 269 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                    TABLE 270 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                    TABLE 271 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                    TABLE 272 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                    TABLE 273 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                    TABLE 274 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                    TABLE 275 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                    TABLE 276 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                    TABLE 277 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                    TABLE 278 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                    TABLE 279 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 280 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 281 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 282 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 283 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                    TABLE 284 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Rising use of AI in clinical decision-making to drive market
                                TABLE 285 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 286 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 287 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 288 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 289 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 290 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 291 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 292 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 293 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 294 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 295 CHINA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 296 CHINA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 297 CHINA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 298 CHINA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 299 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                                TABLE 300 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI solutions
                                TABLE 301 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 302 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 303 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 304 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 305 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 306 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 307 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 308 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 309 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 310 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 311 JAPAN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 312 JAPAN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 313 JAPAN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 314 JAPAN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 315 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                                TABLE 316 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Favorable government initiatives for R&D investments to drive market
                                TABLE 317 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                                TABLE 318 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                                TABLE 319 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                                TABLE 320 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                                TABLE 321 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                                TABLE 322 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                                TABLE 323 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                                TABLE 324 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                                TABLE 325 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
                                TABLE 326 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                                TABLE 327 INDIA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 328 INDIA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 329 INDIA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                TABLE 330 INDIA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                                TABLE 331 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                                TABLE 332 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 333 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                    TABLE 334 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                    TABLE 335 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                    TABLE 336 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                    TABLE 337 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                    TABLE 338 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                    TABLE 339 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                    TABLE 340 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                    TABLE 341 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 342 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 343 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 344 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 345 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 346 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 347 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                    TABLE 348 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS
           9.5.2 LATIN AMERICA: RECESSION IMPACT
                    TABLE 349 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                    TABLE 350 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                    TABLE 351 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
                    TABLE 352 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
                    TABLE 353 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
                    TABLE 354 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
                    TABLE 355 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                    TABLE 356 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                    TABLE 357 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021(USD MILLION)
                    TABLE 358 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
                    TABLE 359 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 360 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 361 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 362 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 363 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                    TABLE 364 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 GROWING HEALTHCARE EXPENDITURE FOSTER GROWTH OF AI
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 365 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
                    TABLE 366 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
                    TABLE 367 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
                    TABLE 368 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
                    TABLE 369 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
                    TABLE 370 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
                    TABLE 371 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
                    TABLE 372 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
                    TABLE 373 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 374 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 375 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 376 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 377 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                    TABLE 378 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
                    TABLE 379 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
                    TABLE 380 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 271)
     10.1 OVERVIEW 
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             TABLE 381 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
     10.3 REVENUE ANALYSIS 
             FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2017–2022
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 34 AI IN MEDICAL DIAGNOSTICS: MARKET SHARE ANALYSIS (2022)
             TABLE 382 AI IN MEDICAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
             FIGURE 35 AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2022)
     10.5 COMPANY EVALUATION MATRIX 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 36 AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022
             10.5.5 COMPANY FOOTPRINT ANALYSIS
                        TABLE 383 OVERALL COMPANY FOOTPRINT (TEN PLAYERS)
                        TABLE 384 APPLICATION (IN VIVO DIAGNOSTIC MODALITIES) FOOTPRINT (TEN PLAYERS)
                        TABLE 385 REGIONAL FOOTPRINT (TEN PLAYERS)
     10.6 START-UP/SME EVALUATION MATRIX 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 DYNAMIC COMPANIES
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 STARTING BLOCKS
                        FIGURE 37 AI IN MEDICAL DIAGNOSTICS MARKET: START0UP/SME EVALUATION MATRIX (2022)
             10.6.5 COMPETITIVE BENCHMARKING
                        TABLE 386 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES
                        TABLE 387 AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
     10.7 COMPETITIVE SCENARIO 
             10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS
                        TABLE 388 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2020–SEPTEMBER 2023
             10.7.2 DEALS
                        TABLE 389 KEY DEALS, JANUARY 2020–SEPTEMBER 2023
             10.7.3 OTHER DEVELOPMENTS
                        TABLE 390 AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS  (JANUARY 2020–SEPTEMBER 2023)
 
11 COMPANY PROFILES (Page No. - 284)
     11.1 KEY PLAYERS 
(Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)*
             11.1.1 MICROSOFT
                        TABLE 391 MICROSOFT: COMPANY OVERVIEW
                        FIGURE 38 MICROSOFT: COMPANY SNAPSHOT (2022)
             11.1.2 NVIDIA CORPORATION
                        TABLE 392 NVIDIA CORPORATION: COMPANY OVERVIEW
                        FIGURE 39 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.3 MERATIVE
                        TABLE 393 MERATIVE: COMPANY OVERVIEW
                        FIGURE 40 IBM: COMPANY SNAPSHOT (2021)
             11.1.4 GOOGLE (ALPHABET, INC.)
                        TABLE 394 GOOGLE: COMPANY OVERVIEW
                        FIGURE 41 GOOGLE: COMPANY SNAPSHOT (2022)
             11.1.5 INTEL CORPORATION
                        TABLE 395 INTEL CORPORATION: COMPANY OVERVIEW
                        FIGURE 42 INTEL CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.6 SIEMENS HEALTHINEERS
                        TABLE 396 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
                        FIGURE 43 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
             11.1.7 GE HEALTHCARE
                        TABLE 397 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             11.1.8 ADVANCED MICRO DEVICES, INC.
                        TABLE 398 ADVANCED MICRO DEVICES, INC.: COMPANY OVERVIEW
                        FIGURE 45 XILINX & ADVANCED MICRO DEVICES, INC.: COMPANY SNAPSHOT (2022)
             11.1.9 KONINKLIJKE PHILIPS N.V.
                        TABLE 399 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 46 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             11.1.10 DIGITAL DIAGNOSTICS, INC.
                        TABLE 400 DIGITAL DIAGNOSTICS, INC.: COMPANY OVERVIEW
             11.1.11 INFORMAI
                        TABLE 401 INFORMAI: COMPANY OVERVIEW
     11.2 OTHER PLAYERS 
             11.2.1 HEARTFLOW, INC.
             11.2.2 ENLITIC, INC.
             11.2.3 AIDENCE
             11.2.4 BUTTERFLY NETWORK, INC.
             11.2.5 NANO X IMAGING LTD.
             11.2.6 VIZ.AI, INC.
             11.2.7 QUIBIM
             11.2.8 QURE.AI
             11.2.9 THERAPIXEL
             11.2.10 AIDOC
             11.2.11 LUNIT, INC.
             11.2.12 ECHONOUS, INC.
             11.2.13 ICOMETRIX
             11.2.14 BRAINOMIX
 
*Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 335)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the AI in medical diagnostics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the AI in medical diagnostics market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, directories, and databases (Dun & Bradstreet, Bloomberg Businessweek, and Factiva, among others) to identify and collect information useful for the technical, market-oriented, and commercial study of AI in medical diagnostics market. Secondary data was collected and analyzed to arrive at the overall size of the global AI in medical diagnostics market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global of AI in medical diagnostics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Hospitals, Clinics and Other Healthcare Facilities, Diagnostic laboratories and Diagnostics Imaging Center, Other End Users- Employer Groups and Government Bodies) and supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, and Rest of the world. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

AI in medical diagnostics Market Size, and Share

Note 1: C-level primaries include CEOs, CFOs, and COOs.

Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million..

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

Microsoft

Product Manager

Digital Diagnostics,Inc.

President

Redcliff Diagnostics

Vice President of Technology

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the size of the AI in medical diagnostics market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details:

  • Revenues of individual companies were gathered from public sources and databases
  • The shares of the AI in medical diagnostics market players were gathered from secondary sources to the extent available. In certain cases, the shares of the businesses were ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach and strength
  • Individual shares or revenue estimates were validated through expert interviews
  • All percentage shares, splits, and breakdowns for the global AI in medical diagnostics market were determined by using secondary sources and verified through primary sources
  • All key macro indicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data
  • The gathered market data was consolidated and added with detailed inputs and analysis and presented in this report

AI in medical diagnostics Market Size: Top Down Approach

AI in medical diagnostics Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the AI in medical diagnostics market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the AI in medical diagnostics market.

Market Definition

Artificial intelligence (AI) refers to the theory and development of computer systems capable of performing tasks that usually require human intelligence. AI involves the study & synthesis of intelligent agents—in this case, a computer system. The system perceives its environment and takes appropriate action to maximize success. AI is being developed to create expert systems and improve human intelligence in machines.

AI is used in the medical diagnostics market to analyze complex data from various imaging modalities and help end users interpret critical data points to diagnose disease conditions.

Key Stakeholders

  • Hospitals
  • Diagnostic care centers
  • Diagnostic laboratories
  • Radiologists and radiology clinics
  • Diagnostic imaging AI device manufacturers and suppliers
  • Medical research laboratories
  • Academic medical centers and universities

Report Objectives

  • To define, describe, and forecast artificial intelligence in the medical diagnostics market based on component, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (RoW)2
  • To profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches/enhancements, expansions, agreements, collaborations, partnerships, and approvals in AI medical diagnostics market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company information

  • Detailed analysis and profiling of additional market players (up to 5)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 7875
Published ON
Oct, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Artificial Intelligence (AI) in Medical Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback